ARCHIVES

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

April 29, 1994

CMS Withholds Coverage of CT Colonography

May 15, 2009

New Food Technology Could Lower Cancer Risk, Greenwald Says; Nutrition Lab Needed

January 27, 1989

NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection

November 7, 1980

COMMIT Moving Into Implementation

July 15, 1988

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977